Misitano & Stracuzzi (MS) H1 2026 earnings summary

Executive summary

• Operates globally in citrus transformation for juices, essential oils, and aromatic solutions, with a strong presence in healthy food and international markets.

• H1 2026 closed with a net loss of €563k, impacted by a 10.4% drop in sales and lower margins.

• Sales revenues for H1 2026 were €36.5 million, down from €40.7 million year-over-year, mainly due to weaker performance in the Americas region.

• Gross margin improved to 26.7% of revenues from 22.9% at FY 2025 year-end, though lower than 28.6% in H1 2025.

• Strategic investments in new production sites and R&D continue, with a focus on efficiency and product innovation.

Financial highlights

• Revenue: €36.5M, down 10.4% year-over-year from €40.7M, mainly due to lower sales in the Americas.

• EBITDA: €1.2M (3.2% margin), down 67.3% from €3.5M (8.6% margin) in H1 2025.

• EBIT: €116k, down 95.5% from €2.6M.

• Net loss: €563k vs. net profit of €1.68M in H1 2025.

• Net financial position improved to -€38.6M from -€40.9M at year-end 2025.

Outlook and guidance

• Financial restructuring agreement signed in September 2026, extending debt maturities and improving liquidity.

• Management expects revenue growth from new high-margin products, international expansion, and operational efficiency from new facilities.

• Cost optimization and efficiency measures underway to support profitability.

• Launch of new production facility in San Filippo del Mela planned.